CHAPEL HILL, NC--Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new mechanism that activates specific genes, leading to the development of cancers.
They showed that a mutation that fuses two unrelated genes can promote a process similar to that observed when oil and water are mixed but do not blend together. The process, called liquid-liquid phase separation, occurs inside a cell's nucleus and enables the formation of compartments with various physical properties that can promote cancers such as acute leukemias. Their findings will be published online June 23, 2021, in Nature.
"Phase separation and its role in cancer has been a missing puzzle piece in understanding this disease," said UNC Lineberger's Greg Wang, PhD, associate professor of Biochemistry and Biophysics and Pharmacology at the UNC School of Medicine and co-lead author of this article. "This finding is among the first to link phase separation to cancer formation."
The discovery brings new insights to a complex, multistep process that bridges biology and physics. To help unravel this process, the investigators performed laboratory experiments in cancer cells that carried a common gene fusion called NUP98-HOXA9. This aberrant fusion is found solely in blood cells of patients that develop leukemia.
"Because similar gene fusions have been observed in other malignancies, the mechanism we elucidated could explain other types of cancer as well," said UNC Lineberger's Douglas H. Phanstiel, PhD, assistant professor of Cell Biology and Physiology at the UNC School of Medicine and co-lead author of this article. "We believe that our research could open up new and innovative avenues to attack cancer cells."
Within the proteins produced by NUP98-HOXA9 are unstructured stretches, known as intrinsically disordered regions, or IDRs. The role of IDRs has been a mystery, but the researchers showed that IDRs promote liquid-liquid phase separation of NUP98-HOXA9 proteins when they reach critical concentrations in the nucleus, causing NUP98-HOXA9 to become phased, or compartmentalized.
"The way that liquid-liquid phase separation alters the behavior of NUP98-HOXA9 proteins is that it makes them bind to target genes much more strongly," said Jeong Hyun Ahn, PhD, a postdoctoral fellow at UNC and first author of this article. "DNA binding of NUP98-HOXA9 proteins, when they are phase-separated, generates a unique pattern called a 'super-enhancer.' Stronger, super enhancer-like binding by NUP98-HOXA9 proteins to DNA leads to more potent activity of this factor, which underlies the formation of aggressive blood cancers."
"Theoretically, a drug that specifically disrupts or dissolves the phase-separated liquid droplets formed by NUP98-HOXA9 could be a therapeutic agent," Wang said. "We hope to look into possible therapeutic agents that target phase separation as we know that this process can also impact neurodegenerative diseases such as Alzheimer's where plaques that build up in the brain may be due, in part, to liquid-liquid phase separation."
The researchers also discovered that phase separation can influence the three-dimensional structure of the genome by creating chromatin loops, which organize the genome and help control which regions are active and which are not. But alterations in this structure can cause human disease when they are aberrantly formed.
"Our discovery is the first clear evidence of chromatin loops formed by phase separation," Phanstiel said. "This new class of loops appears to be driving cancer development by connecting regulatory regions of chromatin to cancer genes, thereby increasing cancer gene expression and lethality."
Taken together, the complex interplay of biology, physics and genetics inside a cell is now better understood due to this latest research finding. Having performed most of their experiments in the lab, the scientists hope to be able to study certain aspects of the process in living organisms and other diseases in the near future.
Authors and disclosures
In addition to Wang, Phanstiel and Ahn, the paper's other authors are Eric S. Davis, Timothy A. Daugird, Shuai Zhao, Ivana Yoseli Quiroga, Hidetaka Uryu, Jie Li, Yi-Hsuan Tsai, Daniel P. Keeley, Ling Cai and Wesley R. Legant, UNC; Aaron J. Storey, Samuel G. Mackintosh, Ricky D. Edmondson, Stephanie D. Byrum, and Alan J. Tackett at the University of Arkansas for Medical Sciences, Little Rock; and Deyou Zheng at the Albert Einstein College of Medicine, Bronx, NY.
The authors declare no competing interests.